A new study published in the journal of BMC Nephrology showed that subcutaneous and intravenous epoetin showed similar ...

Officials with the FDA have approvedthe first generic robenacoxib injectable (Robenacoxib Injection; Cronus Pharma Specialties) for the control of postoperative pain and inflammation in canine and ...

For a heart just damaged by a blocked artery, timing matters. So does access. That is what makes a new experimental treatment ...

Three experimental injectable antiretrovirals – a novel capsid inhibitor and two next-generation integrase inhibitors – could ...

Xeris Biopharma benefits from the FDA's CRL to Corcept's relacorilant, removing a major competitive threat to Recorlev sales ...

Participants received either oral fenebrutinib twice daily or oral teriflunomide once daily for at least 96 weeks.

Zealand Pharma’s shares fell 32% in early morning trading Friday after its Roche-partnered asset petrelintide failed to meet investor expectations in a mid-stage clinical trial.

Among adults with hereditary angioedema, the safety of navenibart up to 24 months was favorable, according to interim trial ...

Orforglipron, a novel oral nonpeptide GLP-1 receptor agonist (RA), led to a greater reduction in A1c and more significant weight loss compared to oral semaglutide in patients with type 2 diabetes (T2D ...

Although HIV infection remains a global public health challenge, ART has transformed it from a fatal illness to a manageable lifetime condition for those who are successfully being treated.Initially, ...

RBL LLC, a pioneering biotech venture creation studio dedicated to rapidly building companies based on breakthrough medical technologies, today announced that portfolio company SteerBio, a biotech ...

This once-weekly C-type natriuretic peptide analog functions by antagonizing overactive FGFR3 signaling to improve growth in pediatric patients.